- Describe the rationale for current investigations into the impact of aortic valve replacement in patients with moderate aortic stenosis (AS)
- Address potential obstacles to timely intervention in patients with moderate to severe AS
- Evaluate key considerations in lifetime management of AS, including long-term valve durability, safety, and efficacy data
Evolving Concepts in Aortic Stenosis: Emerging Evidence, Electronic Notifications, and Optimal Lifetime Management
Please join us for a complimentary CME-certified dinner symposium
Sunday, November 8, 2026
5:30 PM – 6:00 PM CST Registration/Dinner
6:00 PM – 7:30 PM CST Scientific Session
Marriott Marquis Chicago
2121 S Prairie Ave, Chicago, IL 60616
Room: Great Lakes BC, 2nd Floor
PROGRAM DESCRIPTION
Using an interactive case-based approach, the expert faculty will discuss contemporary evidence-based management strategies for patients with aortic stenosis (AS) who may be considered as candidates for transcatheter aortic valve replacement. The faculty will present common and challenging clinical scenarios to model optimal approaches to diagnostic evaluation, risk stratification, procedural planning, and longitudinal care–all informed by the latest clinical trials and registry data on outcomes of intervention in AS. The program will end with a live audience question-and-answer session.
LEARNING OBJECTIVES
At the conclusion of this program, participants should be better able to:
INTENDED AUDIENCE
General cardiologists, internal medicine, cardiology specialties such as heart failure, electrophysiologists who are physicians, advanced practitioners, or other healthcare professionals.
This event is not part of the official Scientific Sessions 2026 as planned by the AHA Committee on Scientific Sessions Programming.
Provided by Haymarket Medical Education
Supported by an educational grant from Edwards Lifesciences, LLC.